GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chugai Pharmaceutical Co 4519.T · JPY

Health Care · Pharmaceuticals · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

6,806

-5.34%

Close of 6 Nov 2026, in JPY

Analyst ratings

20 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 10Buy
  • 7Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 6,806Average target 9,469.24

Low
6,464
Average
9,469.24
Median
9,368.7
High
13,965

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue¥1.38trn¥1.51trn¥1.65trn¥1.84trn¥1.97trn
Revenue, highest¥1.47trn¥1.67trn¥1.90trn¥2.02trn¥2.17trn
Revenue, lowest¥1.35trn¥1.44trn¥1.53trn¥1.75trn¥1.88trn
Earnings per share307.44351.57399.31463.54497.00
Earnings per share, highest341.00386.89445.91523.27561.05
Earnings per share, lowest289.03308.52332.28435.73467.18
Analysts141413116

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast76.8175.6766.3873.4872.6574.8349.3059.82
Reported92.9569.1970.4878.0367.5859.0459.0955.64
Difference+21.0%-8.6%+6.2%+6.2%-7.0%-21.1%+19.9%-7.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

8 / 10

Revenue growth 9.7% a year over 10 years. Return on equity 21.4%.

Model fair value

7,827.95

From earnings 7,827.95, from revenue 7,418.14.

Piotroski score

6 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.